Christopher Yea - May 22, 2024 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
CHIEF DEVELOPMENT OFFICER
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Stock symbol
KALV
Transactions as of
May 22, 2024
Transactions value $
$0
Form type
4
Date filed
5/24/2024, 04:10 PM
Previous filing
May 21, 2024
Next filing
Aug 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALV Restricted Stock Units Award $0 +50K $0.00 50K May 22, 2024 Common Stock 50K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2 1/16th of the total RSUs subject to the Award shall vest on each quarterly anniversary of the vesting commencement date, commencing on August 22, 2024, until fully vested, subject to continued service through each vesting date.